Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Bionano Genomics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before. The highest annual figure on record is $20.08M in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $16.33M | -18.7% |
| FY2019 | Dec 31, 2019 | $20.08M | +122.4% |
| FY2018 | Dec 31, 2018 | $9.03M | +34.2% |
| FY2017 | Dec 31, 2017 | $6.73M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $14.87M | -12.4% |
| Q4 FY2020 | Dec 31, 2020 | $16.33M | -18.7% |
| Q3 FY2020 | Sep 30, 2020 | $16.01M | -14.7% |
| Q2 FY2020 | Jun 30, 2020 | $15.71M | -15.6% |
| Q1 FY2020 | Mar 31, 2020 | $16.97M | -7.7% |
| Q4 FY2019 | Dec 31, 2019 | $20.08M | +122.4% |
| Q3 FY2019 | Sep 30, 2019 | $18.78M | +108.4% |
| Q2 FY2019 | Jun 30, 2019 | $18.62M | +176.7% |
| Q1 FY2019 | Mar 31, 2019 | $18.38M | – |
| Q4 FY2018 | Dec 31, 2018 | $9.03M | – |
| Q3 FY2018 | Sep 30, 2018 | $9.01M | – |
| Q4 FY2017 | Dec 31, 2017 | $6.73M | – |
See a number that looks wrong?